Tumoral CD24 tunes platelets binding and pro-metastatic functions
Vincent Mittelheisser, Cristina Liboni, Clarisse Mouriaux, Silvia Maria Grazia Trivigno, Louis Bochler, María Jesús García-León, Annabel Larnicol, Laetitia Paulen, Tristan Stemmelen, Pierre Mangin, Olivier Lefèbvre, Jacky G. Goetz
This study identifies CD24 as a regulator of tumor cell-platelet interactions that enhance metastatic potential and suggests it as a druggable target.
bioRxiv · Apr 9, 2025 · PreprintCancer Biology